Expanding MedPharm’s US Presence with a New Manufacturing Facility in Durham, North Carolina
June 7, 2021
Over the last 20 years, MedPharm has established a strong worldwide reputation delivering exceptional topical and transdermal solutions. We are thrilled to announce the opening of our new site in Raleigh-Durham, North Carolina, expanding MedPharm’s’ CDMO services in semi-solid and liquid manufacturing.
This new state-of-the-art facility will double our existing footprint and will give our clients the opportunity to manufacture clinical batches and commercial scale products in the US.
Located within a few miles of our existing Center of Excellence for Performance Testing, our team will be able to support clients in process development as well as clinical and small-scale commercial manufacturing for semi-solid and liquid pharmaceutical products.
Eugene Ciolfi, MedPharm’s President and CEO comments on this announcement stating the investment is a clear demonstration of the company’s continued commitment to a global vision by expanding client services downstream into commercial manufacturing.
“MedPharm’s newest facility is an extension of our development services and will support our client base with their clinical and commercial pipelines needs for topical and transdermal products globally.”
The facility is designed to meet all FDA, EMA requirements for GMP production with state-of-the art design, operational support systems, quality management systems and resource management.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm is experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognized for their scientific rigor by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.